Targeting of cellular redox metabolism for mitigation of radiation injury.
Animals
Cyclooxygenase 2
/ metabolism
DNA, Mitochondrial
/ genetics
Epigenesis, Genetic
Humans
Inflammation
Lymphocytes
/ cytology
Mast Cells
/ cytology
Mice
Mitochondria
/ radiation effects
Mutation
NADPH Oxidases
/ metabolism
Nitric Oxide
/ metabolism
Nitric Oxide Synthase Type II
/ metabolism
Oxidation-Reduction
Oxidative Stress
/ radiation effects
Radiation Injuries
/ metabolism
Radiation, Ionizing
Reactive Oxygen Species
/ metabolism
Ionizing radiation
Metabolism
Mitochondria
Nitric oxide (NO)
Normal tissue injury
ROS
Journal
Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521
Informations de publication
Date de publication:
01 Jun 2020
01 Jun 2020
Historique:
received:
05
02
2020
revised:
17
03
2020
accepted:
17
03
2020
pubmed:
25
3
2020
medline:
6
5
2020
entrez:
25
3
2020
Statut:
ppublish
Résumé
Accidental exposure to ionizing radiation is a serious concern to human life. Studies on the mitigation of side effects following exposure to accidental radiation events are ongoing. Recent studies have shown that radiation can activate several signaling pathways, leading to changes in the metabolism of free radicals including reactive oxygen species (ROS) and nitric oxide (NO). Cellular and molecular mechanisms show that radiation can cause disruption of normal reduction/oxidation (redox) system. Mitochondria malfunction following exposure to radiation and mutations in mitochondria DNA (mtDNA) have a key role in chronic oxidative stress. Furthermore, exposure to radiation leads to infiltration of inflammatory cells such as macrophages, lymphocytes and mast cells, which are important sources of ROS and NO. These cells generate free radicals via upregulation of some pro-oxidant enzymes such as NADPH oxidases, inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Epigenetic changes also have a key role in a similar way. Other mediators such as mammalian target of rapamycin (mTOR) and peroxisome proliferator-activated receptor (PPAR), which are involved in the normal metabolism of cells have also been shown to regulate cell death following exposure to radiation. These mechanisms are tissue specific. Inhibition or activation of each of these targets can be suggested for mitigation of radiation injury in a specific tissue. In the current paper, we review the cellular and molecular changes in the metabolism of cells and ROS/NO following exposure to radiation. Furthermore, the possible strategies for mitigation of radiation injury through modulation of cellular metabolism in irradiated organs will be discussed.
Identifiants
pubmed: 32205088
pii: S0024-3205(20)30318-0
doi: 10.1016/j.lfs.2020.117570
pii:
doi:
Substances chimiques
DNA, Mitochondrial
0
Reactive Oxygen Species
0
Nitric Oxide
31C4KY9ESH
NOS2 protein, human
EC 1.14.13.39
Nitric Oxide Synthase Type II
EC 1.14.13.39
Nos2 protein, mouse
EC 1.14.13.39
Ptgs2 protein, mouse
EC 1.14.99.-
Cyclooxygenase 2
EC 1.14.99.1
NADPH Oxidases
EC 1.6.3.-
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
117570Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest None.